Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety of clevidipine in the treatment of
postoperative hypertension. Approximately 250-500 patients with postoperative hypertension
after undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass
(OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve
replacement/repair procedures were anticipated to be randomly assigned to one of two
treatment groups: clevidipine or nicardipine.